1.The RUNX3 mRNA expression in hepatic cell carcinoma(HCC).
Yan-hui LU ; Cheng-ru XU ; Jie CHEN ; Rui-dan ZHENG ; Jian-guo LI ; Zhi-chuan LIN
Chinese Journal of Hepatology 2011;19(12):940-941
2.Expression of RUNX3 protein in nasopharyngeal carcinoma by tissue microarray.
Hua ZHANG ; Su-ping ZHAO ; Li-juan MA
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2007;42(10):779-780
Adolescent
;
Adult
;
Aged
;
Carcinoma
;
metabolism
;
pathology
;
Core Binding Factor Alpha 3 Subunit
;
metabolism
;
Female
;
Humans
;
Male
;
Middle Aged
;
Nasopharyngeal Neoplasms
;
metabolism
;
pathology
;
Protein Array Analysis
;
methods
;
Young Adult
3.Differential bone metabolism and protein expression in mice fed a high-fat diet versus Daurian ground squirrels following natural pre-hibernation fattening.
Xuli GAO ; Shenyang SHEN ; Qiaohua NIU ; Weilan MIAO ; Yuting HAN ; Ziwei HAO ; Ning AN ; Yingyu YANG ; Yu ZHANG ; Han ZHANG ; Kenneth B STOREY ; Hui CHANG
Journal of Zhejiang University. Science. B 2022;23(12):1042-1056
This study compared the effects on bone metabolism and morphology of pathological obesity induced by excessive fat intake in a non-hibernator (mice) versus healthy obesity due to pre-hibernation fattening in a hibernator (ground squirrels). Kunming mice were fed a high-fat diet to provide a model of pathological obesity (OB group). Daurian ground squirrels fattened naturally in their pre-hibernation season (PRE group) were used as a healthy obesity model. Micro-computed tomography (micro-CT) and three-point bending tests were used to determine the microstructure and mechanical properties of bone. Western blots were used to analyze protein expression levels related to bone metabolism (Runt-related transcription factor 2 (RunX2), osteocalcin (OCN), alkaline phosphatase (ALP), osteoprotegerin (OPG), receptor activator of nuclear factor-κB ligand (RANKL), cathepsin K, matrix metallopeptidase 9 (MMP9), patched protein homolog 1 (Ptch1), phosphorylated β-catenin (P-β-catenin), and glycogen synthase kinase-3β (GSK-3β)). Compared with controls, there was no obvious bone loss in the OB mice, and the stiffness of the femur was increased significantly. Compared with summer active squirrels, bone formation was enhanced but the mechanical properties did not change in the PRE group squirrels. In OB mice, western blots showed significantly increased expression levels of all proteins except RunX2, OPG, and Ptch1. PRE ground squirrels showed significantly increased expression of most proteins except OCN and Ptch1, which decreased significantly, and P-β-catenin and OPG, which did not change. In conclusion, for non-hibernating mice, moderate obesity had a certain protective effect on bones, demonstrating two-way regulation, increasing both bone loss and bone formation. For pre-hibernating ground squirrels, the healthy obesity acquired before hibernation had a positive effect on the microstructure of bones, and also enhanced the expression levels of proteins related to bone formation, bone resorption, and Wnt signaling.
Mice
;
Animals
;
Hibernation
;
Core Binding Factor Alpha 1 Subunit/metabolism*
;
Glycogen Synthase Kinase 3 beta/metabolism*
;
Diet, High-Fat
;
X-Ray Microtomography
;
Sciuridae/metabolism*
;
Obesity
4.Promoter methylation and expression of Runx3 gene in gastric cancer.
Li-Yi LI ; Ji-Kun LI ; Yun SHEN ; Liang YU ; Jian-Hai ZHANG
Chinese Journal of Gastrointestinal Surgery 2008;11(4):379-382
OBJECTIVETo analyze the relationships among the aberrant methylation of Runx3 gene promoter, the Runx3 protein expression and clinicopathological features in gastric cancer.
METHODSMethylation specific PCR was used to measure the promoter methylation status of Runx3 gene in tumor and the adjacent normal mucosal tissues from 40 patients with gastric cancer. Protein expression of Runx3 was measured by immunohistochemistry.
RESULTSThe frequency of promoter methylation of Runx3 gene in gastric cancer tissue(55.0%) was significantly higher compared to the adjacent normal tissues (12.5%)(P<0.01). The positive rate of protein expression of Runx3 in gastric cancer tissue(37.5%) was significantly lower compared to the adjacent normal tissues (100%). There was marked association between hypermethylation and negative protein expression (P<0.05). The frequency of Runx3 promoter methylation was associated with histological type, N grade, and tumor stage.
CONCLUSIONThe promoter hypermethylation is a main mechanism of reduced or loss expression of Runx3 gene, which may provide molecular diagnosis and stage evaluation of gastric cancer.
Adult ; Aged ; Core Binding Factor Alpha 3 Subunit ; genetics ; metabolism ; CpG Islands ; DNA Methylation ; Female ; Humans ; Middle Aged ; Neoplasm Staging ; Promoter Regions, Genetic ; Stomach Neoplasms ; diagnosis ; metabolism ; pathology
6.Reappraisal of the impacts of human Runt-related transcription factor gene 3 expression on differentiation and prognosis of gastric cancer.
Bei-wen WU ; Jun ZHANG ; Xu-feng FEI ; Zheng-gang ZHU ; Wei-xin CAO
Chinese Journal of Gastrointestinal Surgery 2007;10(2):165-168
OBJECTIVETo investigate the expression of Runt-related transcription factor gene 3(RUNX3) in gastric cancer and its impact on the outcome of gastric cancer patients.
METHODSBy using immunohistochemistry staining and western blot assay, the expression of RUNX3 protein in 66 cases of gastric cancer with various clinicopathologic characteristics were detected, and the effects of RUNX3 protein expression on the outcome of patients undergone surgical resection were evaluated.
RESULTS(1) The expression rate of RUNX3 protein in gastric cancer lesions was 60.6% (40/66), and RUNX3 protein was mainly expressed in the cytoplasm of cancer cells. RUNX3 protein expression in tumor tissues was significantly higher than that in non-tumor tissues. (2) RUNX3 protein expression was correlated with tumor differentiation (P=0.025) and Lauren's classification (P=0.034), but had no relationship with the TNM stage (P=0.085). (3) In sharp contrast, the median survival time of patients who had tumors with negative and positive RUNX3 protein expression were 2478 and 2187 days respectively (P=0.016).
CONCLUSIONSRUNX3 protein influences the differentiation of gastric cancer. The role of RUNX3 protein as a tumor-suppressor in tumorigenesis and differentiation of gastric carcinoma need to be further evaluated.
Aged ; Cell Differentiation ; Core Binding Factor Alpha 3 Subunit ; genetics ; metabolism ; Female ; Humans ; Immunohistochemistry ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Stomach Neoplasms ; genetics ; pathology
7.Mouse whole mount RNA in situ hybridization: an effective technique for analyzing gene expression.
Cui-ying XIAO ; Ditsa LEVANON ; Si-zhong ZHANG ; Yoram GRONER
Chinese Journal of Medical Genetics 2004;21(1):47-51
OBJECTIVETo set up a method of analyzing gene expression profile from mouse whole embryos.
METHODSMouse whole mount RNA in situ hybridization(WM-ISH) of E10.5-E14 embryos was carried out by using digoxigenin-labeled Runx1 and Runx3 RNA probes and their expression profile was observed by detecting the existence and status of corresponding mRNAs in the embryonic tissues.
RESULTSClear hybridization signals were observed in different tissues and organs hybridized by Runx1 or Runx3 RNA probe. Different probes and ages of embryos had need of their own optimal proteinase K treatment conditions.
CONCLUSIONMouse whole mount RNA in situ hybridization is an effective method of analyzing gene expression. It is useful for revealing whole gene expression profile and has a great potentiality in the era of functional genomics. It provides an alternative method of studies on gene expression which is at least as good as LacZ staining and immunohistochemistry. The key factor of the success to mouse whole mount RNA in situ hybridization is whether the proteinase K treatment conditions are optimal or not.
Animals ; Core Binding Factor Alpha 2 Subunit ; Core Binding Factor Alpha 3 Subunit ; DNA-Binding Proteins ; genetics ; Embryo, Mammalian ; metabolism ; Gene Expression Profiling ; methods ; Gene Expression Regulation, Developmental ; In Situ Hybridization ; methods ; Mice ; Proto-Oncogene Proteins ; genetics ; RNA ; genetics ; metabolism ; RNA, Messenger ; genetics ; metabolism ; Sensitivity and Specificity ; Transcription Factors ; genetics
8.Methylation of Runx3 promoter in different breast lesions.
Xiaojiang WANG ; Xiongwei ZHENG ; Xiandong LIN ; Yi SHI ; Yinzhu HE ; Gang CHEN
Chinese Journal of Pathology 2014;43(7):447-450
OBJECTIVETo investigate the methylation status of Runx3 promoter and Runx3 expression in breast lesion tissues.
METHODSOne hundred and fourteen breast lesions, including 35 cases of fibroadenoma, 39 cases of intraductal carcinoma, 40 cases of invasive ductal carcinoma, and 33 cases of normal breast tissue from Fabruary 2010 to August 2012 were included in this study. Runx3 protein expression was assessed by immunohistochemical SP method; whereas methylation of Runx3 promoter was assessed by high resolution melting (HRM) analysis.
RESULTSRunx3 protein was mainly expressed in the cytoplasm of ductal epithelial cells. The expression rates of Runx3 in normal breast tissue, fibroadenoma, ductal carcinoma in situ, invasive ductal carcinoma were 87.9% (29/33), 85.7% (30/35), 53.8% (21/39), and 40.0% (16/40) respectively. The methylation rates of Runx3 promoter were 12.1% (4/33), 20.0% (7/35), 46.2% (18/39), and 57.5% (23/40), respectively. Correlation analysis between promoter methylation and protein expression of Runx3 in different breast tissue showed the r value in normal breast tissue, fibroadenoma, ductal carcinoma in situ and invasive ductal carcinoma was -0.431 (P = 0.012), -0.408 (P = 0.015), -0.589 (P = 0.000) and -0.743 (P = 0.000) respectively.
CONCLUSIONSRunx3 protein expression shows a downward trend in ductal carcinoma in situ and invasive ductal carcinoma, meanwhile its promoter methylation increases significantly. The methylation of Runx3 promoter may be one of the important factors in the occurrence and development of breast cancer.
Breast ; metabolism ; Breast Neoplasms ; metabolism ; Carcinoma, Ductal, Breast ; metabolism ; Carcinoma, Intraductal, Noninfiltrating ; metabolism ; Core Binding Factor Alpha 3 Subunit ; genetics ; metabolism ; DNA Methylation ; Female ; Fibroadenoma ; metabolism ; Humans ; Neoplasm Proteins ; metabolism ; Promoter Regions, Genetic
9.Correlation between the methylation status of Runx3 gene and positive expression of estrogen receptor in breast cancer.
Zhantao YAN ; Shan GAO ; Xia WU ; Hui LIU ; E-mail: 13952269920LHH@163.COM.
Chinese Journal of Pathology 2015;44(4):240-244
OBJECTIVETo investigate the relationship between hypermethylation of Runx3 gene promoter and estrogen receptor (ER) and the implications of Runx3 gene promoter hypermethylation in ER positive breast cancer.
METHODSWestern blot and RT-PCR were used to detect the protein and mRNA expression of Runx3 gene in breast cancer cell lines (MCF7 and SKBR3) and normal breast epithelium cell line (MCF10A). Immunohistochemical SP method was used to detect the expression of ER and Runx3 proteins in 113 tissue samples of breast cancer. Moreover, methylation specific PCR was used to detect RUN3 promoter methylation in cell lines MCF7, SKBR3, MCF10A and 113 tissue samples of breast cancer.
RESULTSOf the 3 cell lines, Runx3 protein and mRNA were detectable in MCF10A, but were absent in MCF7 and SKBR3. MCF7 had a high methylation status at Runx3 promoter, in contrast, MCF10A and SKBR3 showed unmethylated RUN3 promoter. Among the 113 cases of breast cancer, 68 cases were ER positive and 45 were negative. The positive rates of Runx3 protein expression in ER positive and negative tumors were 26.5% (18/68) and 66.7% (30/45), respectively (P<0.05). Runx3 promoter hypermethylation was seen in 82.4% (56/68) of ER positive breast cancer cases and 22.2% (10/45) of ER negative ones (P<0.05). Among 68 cases of ER positive cases, Runx3 promoter hypermethylation was positively correlated with the clinical tumor stage (OR=5.84, P<0.05).
CONCLUSIONSRunx3 gene promoter hypermethylation is present mainly in the ER positive breast cancers. Testing of Runx3 promoter methylation may provide additional reference for clinical stage and prognosis of breast cancer patients, especially in those with ER positive tumors.
Breast Neoplasms ; genetics ; metabolism ; Cell Line, Tumor ; Core Binding Factor Alpha 3 Subunit ; genetics ; metabolism ; DNA Methylation ; Female ; Humans ; Neoplasm Proteins ; genetics ; metabolism ; Polymerase Chain Reaction ; methods ; Prognosis ; Promoter Regions, Genetic ; RNA, Messenger ; metabolism ; Receptors, Estrogen ; genetics ; metabolism
10.Expression of RUNX3 in cervical carcinoma and its clinical significance.
Yuping DENG ; Meifang NIE ; Fengying LIU ; Shan JIANG ; Yizhi LIU ; Dengqing LI ; Qucheng MENG ; Jin LI ; Minzhu HUANG ; Mingming WANG
Journal of Central South University(Medical Sciences) 2011;36(12):1189-1194
OBJECTIVE To explore the role of runt-related transcription factor 3(RUNX3) in the tumorgenesis and progression of cervical carcinoma. METHODS The immunohistochemical staining technique was used to detect the expression of RUNX3 protein in 25 cases of normal cervix, 34 intraepithelia neoplasia (CIN), and 48 cervical carcinomas. SYBR Green I chimeric fluorescence Real-time PCR was applied to detect the expression of RUNX3 mRNA in 10 cases of normal cervix, 24 CIN, and 30 cervical carcinomas. RESULTS The expressions of RUNX3 protein and mRNA in normal cervix, CINI,CINII-III, and cervical carcinoma tissues tended to be down-regulated. There was significant difference among these groups (P<0.05). The expressions of RUNX3 protein and mRNA in the cervical carcinoma tissues were correlated with the histological differentiation, clinical stage, and lymphatic metastasis (P<0.05), but had no relationship with the age, high-risk human papillomavirus infection, and histological classification (P> 0.05). CONCLUSION RUNX3 may function as a tumor suppressor gene in the occurrence and progression of cervical carcinoma.
Adult
;
Carcinoma, Squamous Cell
;
genetics
;
metabolism
;
Cervical Intraepithelial Neoplasia
;
genetics
;
metabolism
;
Core Binding Factor Alpha 3 Subunit
;
genetics
;
metabolism
;
Disease Progression
;
Female
;
Humans
;
Middle Aged
;
RNA, Messenger
;
genetics
;
metabolism
;
Uterine Cervical Neoplasms
;
genetics
;
metabolism